跳转至内容
Merck
CN
  • Development of an electrophoretic method based on nanostructured materials for HbA1c determination.

Development of an electrophoretic method based on nanostructured materials for HbA1c determination.

Electrophoresis (2018-02-01)
Mariana Hamer, Narella Bassi, Denise Agata Grela
摘要

Glycosylated hemoglobin (HbA1c) detection is performed routinely in hospitals as it is the most widespread confirmatory diagnosis of diabetes mellitus. Here we present a novel CE method for measuring HbA1c by introducing silica nanoparticles (NPs) modified with a boronic acid derivative (sugar loadings of 51 ± 2 μg/mg) as pseudo-stationary phase. Before the sample injection, SiO2 NP─B(OH)2 were introduced via pressure. Electrophoretic separation was explored through variation of the buffer pH and separation voltage, being the best separation, resolution and shorter separation time achieved with a 25 mM phosphate buffer pH 6.5. The calibration curve obtained was expressed as Area = 182.05%-1 × HbA1c - 377.02; R2  = 0.9826, using a UV/VIS absorbance detector at 415 nm (diode array). No interferences were observed from carbamylated or acetylated hemoglobin and the method shows a noteworthy stability. A paired t-test was applied to compare the developed CE method with a commercial HbA1c test and no significant variations have been observed at a 90% significance level.